ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

China expands testing to 18 nations in vaccine charm offensive

Beijing targets Belt and Road countries but safety concerns persist

A COVID-19 vaccine candidate from Sinovac Biotech. Three Chinese companies are now conducting Phase 3 trials abroad.   © Reuters

DALIAN/BEIJING -- China is on track to conduct final clinical trials for a coronavirus vaccine in 18 countries by the end of the year, bolstering its vaccine diplomacy in emerging economies that are struggling to contain the virus.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more